Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Damdinova LV, Leshchenko OYa. Polycystic ovary syndrome – 80 years of research and new directions in the study (literature review). Biulleten' VSNTs SO RAMN. 2016;15(111):181-185. doi:10.12737/23421. (in Russian).
Mohort TV, Velesevich EI, Yurenya EV, Shyshko VM, Tsinkevich AI. Polycystic ovary syndrome: what's new? (Based on an Endocrine Society Clinical Practice Guideline). Meditsinskie novosti. 2014;(12):16-21. (in Russian).
Pankiv IV, Korytko OO. Vitamin D level, frequency of its insufficiency and deficiency in patients with polycystic ovary syndrome. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(6):585-589. doi:10.22141/2224-07188.8.131.528.146069. (in Ukrainian).
Niu YM, Wang YD, Jiang GB, et al. Association between vitamin D receptor gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis. Front Physiol. 2019;9:1902. doi:10.3389/fphys.2018.01902.
Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009;139(2):329-334. doi:10.3945/jn.108.093831.
Larsson S, Jones HA, Göransson O, Degerman E, Holm C. Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase. Cell Signal. 2016;28(3):204-213. doi:10.1016/j.cellsig.2015.12.012.
Maestro B, Dávila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2-3):223-230. doi:10.1016/s0960-0760(03)00032-3.
Shojaeian Z, Sadeghi R, Latifnejad Roudsari R. Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ocvary syndrome: A systematic review and meta-analysis. Caspian J Intern Med. 2019;10(4):359-369. doi:10.22088/cjim.10.4.359.
Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3):460-464. doi:10.1210/jcem-67-3-460.
Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171(4):P1-P29. doi:10.1530/EJE-14-0253.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi:10.1210/jc.2011-0385.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. doi:10.1007/BF00280883.
Kaminskyi OV, Pankiv VI, Pankiv IV, Afanasyev DE. Vitamin D content in population of radiologically contaminated areas in Chernivtsi oblast (pilot project). Probl Radiac Med Radiobiol. 2018;23:442-451. doi:10.33145/2304-8336-2018-23-442-451.
Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol. 2014;30(6):397-402. doi:10.3109/09513590.2014.887673.
Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619-2625. doi:10.2337/db08-0593.
Nikolova MG, Boyanov MA, Tsakova AD. Correlations of serum vitamin D with metabolic parameters in adult outpatients with different degrees of overweight/obesity coming from an urban community. Acta Endocrinol (Buchar). 2018;14(3):375-383. doi:10.4183/aeb.2018.375.
Moran LJ, Teede HJ, Noakes M, Clifton PM, Norman RJ, Wittert GA. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome. J Endocrinol Invest. 2013;36(11):1004-1010. doi:10.3275/9023.
Deswal R, Yadav A, Dang AS. Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis. Syst Biol Reprod Med. 2018;64(1):12-24. doi:10.1080/19396368.2017.1410591.